CATALOGO DEI PRODOTTI DELLA RICERCA

CALIÒ, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.554
EU - Europa 4.956
AS - Asia 3.923
SA - Sud America 689
Continente sconosciuto - Info sul continente non disponibili 332
AF - Africa 150
OC - Oceania 16
Totale 15.620
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.377
RU - Federazione Russa 2.057
SG - Singapore 1.529
CN - Cina 1.016
GB - Regno Unito 858
IT - Italia 688
BR - Brasile 544
HK - Hong Kong 399
VN - Vietnam 381
DE - Germania 263
SE - Svezia 263
IE - Irlanda 221
FR - Francia 208
BD - Bangladesh 136
FI - Finlandia 120
KR - Corea 120
CA - Canada 91
IN - India 74
AR - Argentina 60
JP - Giappone 51
UA - Ucraina 51
NL - Olanda 43
MX - Messico 40
ID - Indonesia 34
IQ - Iraq 31
NG - Nigeria 29
PL - Polonia 28
BE - Belgio 27
ES - Italia 27
TR - Turchia 27
BJ - Benin 24
EC - Ecuador 22
TG - Togo 21
ZA - Sudafrica 19
VE - Venezuela 18
AT - Austria 17
CO - Colombia 17
SA - Arabia Saudita 17
MA - Marocco 16
LT - Lituania 13
AU - Australia 12
CH - Svizzera 11
PK - Pakistan 11
TN - Tunisia 11
CR - Costa Rica 10
JM - Giamaica 9
PY - Paraguay 9
UZ - Uzbekistan 9
EG - Egitto 8
CL - Cile 7
IR - Iran 7
LB - Libano 7
PH - Filippine 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
DK - Danimarca 6
HN - Honduras 6
IL - Israele 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
JO - Giordania 5
KZ - Kazakistan 5
MY - Malesia 5
GR - Grecia 4
NP - Nepal 4
PS - Palestinian Territory 4
PT - Portogallo 4
RO - Romania 4
TW - Taiwan 4
UY - Uruguay 4
BH - Bahrain 3
BO - Bolivia 3
BS - Bahamas 3
DZ - Algeria 3
HR - Croazia 3
KE - Kenya 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AO - Angola 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CM - Camerun 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KW - Kuwait 2
KY - Cayman, isole 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
LY - Libia 2
NI - Nicaragua 2
PR - Porto Rico 2
RS - Serbia 2
SI - Slovenia 2
Totale 15.254
Salva come PNG Salva come JPEG
Città #
Singapore 807
Ashburn 746
Southend 688
Moscow 661
Dallas 632
San Jose 609
Chandler 416
Hong Kong 382
Council Bluffs 274
Dublin 219
Verona 215
Beijing 206
The Dalles 189
Woodbridge 159
Jacksonville 152
Ann Arbor 138
New York 120
Los Angeles 118
Ho Chi Minh City 108
Munich 87
Hanoi 84
Santa Clara 69
Lawrence 68
Princeton 68
Houston 67
Wilmington 67
Jinan 61
São Paulo 61
Milan 55
Redondo Beach 52
Buffalo 51
London 50
Helsinki 49
Shenyang 47
Tokyo 46
Columbus 44
Rome 43
Redmond 42
Tianjin 35
Hebei 34
Orem 34
Nanjing 33
Sindelfingen 31
Seattle 29
Toronto 28
Abuja 27
Bologna 27
Phoenix 27
Montreal 26
Ningbo 26
Turku 25
Changsha 24
Cotonou 24
Chennai 23
Warsaw 23
Brussels 22
Chicago 22
Frankfurt am Main 22
Redwood City 22
Lomé 21
Mexico City 21
Hangzhou 20
Nuremberg 20
Brooklyn 19
Da Nang 19
Rio de Janeiro 19
Seoul 19
Guangzhou 18
Zhengzhou 18
Amsterdam 17
Atlanta 17
Haiphong 17
Lancaster 17
Taizhou 17
Boston 16
Jakarta 16
Johannesburg 15
Madrid 15
Nanchang 15
Baghdad 14
Biên Hòa 14
Denver 14
San Francisco 14
Belo Horizonte 13
Stockholm 13
Taiyuan 13
Boardman 12
Dearborn 12
Fortaleza 12
Manchester 12
Shanghai 12
Charlotte 11
Guayaquil 11
Naples 11
Fairfield 10
Haikou 10
Norwalk 10
Washington 10
Ankara 9
Chongqing 9
Totale 9.116
Salva come PNG Salva come JPEG
Nome #
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis 255
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 251
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 248
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 244
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 236
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 225
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 218
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 217
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 217
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 216
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 209
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 203
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 198
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 196
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 192
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 192
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 182
Cathepsin K expression in clear cell "sugar" tumor (PEComa) of the lung 181
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 181
A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss 180
Pancolitis with ischemic injury as a complication of immunosuppressive treatment in a patient with autoimmune hepatitis: a case report. 179
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 179
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification 178
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 177
Primary Seminal Vesicle Carcinoma. The Usefulness of Pax8 Immunohistochemical Expression for the Differential Diagnosis 176
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 173
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 167
Increased Frequency of Bronchiolar Histotypes in Lung Carcinomas Associated with Idiopathic Pulmonary Fibrosis 166
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 166
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis 165
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 165
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 164
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation 163
From fine-needle aspiration cytology to fluorescent in-situ hybridization in an unusual case of pharyngeal synovial sarcoma 163
Multifocal Hepatic Angiosarcoma with Atypical Presentation: Case Report and Literature Review 160
2022-RA-1535-ESGO Uterine PEComa and prognostic value of the proposed classification systems: a retrospective study, systematic review, and metanalysis 159
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 154
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 152
Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer? 151
Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications 150
MiT family translocation renal cell carcinoma: looking for diagnostic and druggable markers 150
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour 147
Intestinal-type primary vaginal adenocarcinoma. Review of the literature with report of a case: from diagnosis to management 147
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 145
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 144
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 143
Recurrent primary endobronchial fetal rhabdomyoma: a case report and literature review 141
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 138
Histology and immunohistochemical evaluation of phimotic prepuce: The role of steroid therapy 137
Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases 132
Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma 131
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022) 131
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 131
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives 130
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 130
High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment 127
Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys 127
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 125
Renomedullary Interstitial Cell Tumors: Pathologic Features and Clinical Correlations 123
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 122
Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens 121
Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation 121
Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma 116
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 115
Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases 115
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 110
Robot-assisted excision of hemangioma of the right renal vein 109
VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations 108
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 108
♂♀ Mixed Epithelial and Stromal Tumors of the Kidney 107
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey 106
Interobserver Agreement in Immunohistochemical Evaluation of Folate Receptor Alpha (FRα) in Ovarian Cancer: A Multicentre Study 105
Small renal masses in young adults: Insights from a large contemporary multi-institutional Registry 105
Papillary Adenomas and Other Small Epithelial Tumors in the Kidney: An Autopsy Study 103
Uterine perivascular epithelioid cell tumors (PEComa) and the accuracy of proposed classification systems in predicting the malignant versus non-malignant behavior 102
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma 102
Epithelioid angiomyolipoma: a pathological entity discovered in Verona with the endorsement of Doctor Rosai 102
Well-differentiated neuroendocrine tumor of the urinary bladder expressing GATA 3 101
Determinants of oncologic outcomes in high-grade organ-confined prostate cancer after prostatectomy 101
HER2 Aberrations in NSCLC: So Close Yet So Far 101
Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'? 101
Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press 101
Patient Selection for Active Surveillance for Small Renal Masses: A Systematic Review of the Literature 99
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 98
Pathological features and clinical associations of 58 small incidental angiomyolipomas of the kidney. 96
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas 94
SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation 93
Hot topics in renal cancer pathology: implications for clinical management 91
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 91
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 91
Identification of diagnostic and predictive morphological and molecular markers in renal tumors 89
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data 87
Interleukin-8 as a potential prognostic biomarker in Renal Cell Carcinoma: A systematic review and Meta-Analysis 87
A modified Delphi consensus statement on the role of biopsy in small renal masses 87
Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations 84
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations 83
Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centers 83
WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist 83
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est) 81
Histology for nephrology, from pre-implantation to post-transplant kidney biopsy. Lesson learned from ReBIrth (Renal BIopsy for Kidney Transplantation Therapy) 78
Totale 14.204
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.252
article - articoli 52.944
book - libri 0
conference - conferenze 1.116
curatela - curatele 0
other - altro 775
patent - brevetti 0
selected - selezionate 0
volume - volumi 417
Totale 110.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022533 0 151 3 69 29 26 17 37 20 14 42 125
2022/20231.260 80 134 105 220 99 330 19 65 130 21 33 24
2023/2024786 35 55 73 73 88 127 42 54 22 48 122 47
2024/20252.415 124 136 185 319 93 76 128 96 313 231 268 446
2025/20267.962 508 451 724 1.223 1.826 473 695 448 644 483 247 240
2026/2027464 188 276 0 0 0 0 0 0 0 0 0 0
Totale 15.620